Context Therapeutics Inc (CNTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.24M
Last updated: Nov 17, 2026 at 4:41 PM ET
Context Therapeutics Inc (CNTX) Stock Chart
Context Therapeutics (CNTX) has a latest price of $0.17 on Nov 17, 2026, 95.3% below its 52-week high of $3.62. Its price fell 85.3% over the past 12 months. The month-end price fell 96.7% over the 5 years through Oct 2026, a compound annual decline of 49.5%.
Price Chart
From Oct 2021 to Oct 2026, its highest month-end close was $6.88 in Nov 2021 and its lowest $0.19 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CNTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CNTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 64.9%, and over 6 months it fell 92.1%. The month-end price fell 82.2% over the 3 years through Oct 2026, a compound annual decline of 43.7%.
| Period | Change |
|---|---|
| 1 month | -28.3% |
| 3 months | -64.9% |
| 6 months | -92.1% |
| 12 months | -85.3% |
| 12 months, with dividends | -85.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -82.2% | -43.7% |
| 5 years | -96.7% | -49.5% |
Price by Year
Its best calendar year was 2023, when the price rose 73.4%, and its weakest was 2022, when it fell 75.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.19 | -87.1% |
| 2025 | $1.47 | +40.0% |
| 2024 | $1.05 | -7.1% |
| 2023 | $1.13 | +73.4% |
| 2022 | $0.65 | -75.5% |
Trading Range
The price is 38.2% below its 50-day average of $0.28 and 87.3% below its 200-day average of $1.35.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.17 | |
| 52-week high | $3.62 | -95.3% |
| 52-week low | $0.16 | +8.2% |
| 50-day average | $0.28 | -38.2% |
| 200-day average | $1.35 | -87.3% |
Price Risk
Over 3 years, its largest fall from a peak was 95.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.38 |
| Largest fall, 1 year | -95.1% |
| Largest fall, 3 years | -95.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CNTX
What is CNTX's 1-year price change?
Context Therapeutics's price fell 85.3% over the past 12 months. With dividends included, the 12-month total return was -85.3%.
What is CNTX's 5-year price change?
Context Therapeutics's month-end price fell 96.7% over the 5 years through Oct 2026, a compound annual decline of 49.5%. These figures leave out dividends.
What is CNTX's 52-week high and low?
Context Therapeutics's 52-week high is $3.62 and its 52-week low is $0.16. Its latest price of $0.17 on Nov 17, 2026 is 95.3% below the high.
What is CNTX's beta?
Context Therapeutics's 1-year beta against the S&P 500 is 0.38, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 95.1%.
Is the CNTX chart free?
Yes. Advanced Charting for CNTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CNTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors